lysine has been researched along with Head and Neck Neoplasms in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, W; Dai, Y; Dong, X; Lai, L; Lu, Y; Shen, L; Tang, D; Tang, J; Xie, H; Yin, L; Zeng, Z; Zhang, Z; Zuo, W | 1 |
| Cheng, T; Huang, F; Zhang, Y; Zhou, Z | 1 |
| Cao, Z; Jiang, L; Xu, W; Yin, X; Zhang, H; Zhang, X; Zhou, M | 1 |
| Hammami, B; Hamza-Chaffai, A; Kallel, I; Khlifi, R; Rebai, A | 1 |
| Alharbi, SA; Basha, J; Bhat, A; Chatterjee, S; Chinnathambi, A; Dharmarajan, A; Kundu, TK; Li, F; Ramakrishnan, GB; Selvi, RB; Sethi, G; Shanmugam, MK; Siveen, KS; Swaminathan, A; Vasudevan, M; Zayed, ME | 1 |
| Deng, X; Dohmae, N; Hamamoto, R; Kiyotani, K; Lingen, M; Matsuo, Y; Nakamura, Y; Park, JH; Saloura, V; Suzuki, T; Vougiouklakis, T; Zewde, M | 1 |
| Banerjee, R; Bradford, C; Cao, Q; Carey, T; Chinnaiyan, AM; D'Silva, NJ; Inglehart, RC; Jing, X; Kalyana-Sundaram, S; Mani, RS; Metwally, T; Palanisamy, N; Russo, N; Scanlon, CS; Tomlins, S; Tsodikov, A; Varambally, S; Wolf, G | 1 |
| Hou, X; Pan, X; Wang, L; Zhang, L; Zhao, W | 1 |
| Choi, EJ; Kim, JS; Kim, YH; Seo, JH; Whang, YM; Yoo, YD | 1 |
| Cortes-Funes, H; Gamarra, S; Hitt, R; Manso, L; Medina, PP; Quintela-Fandino, M; Sanchez-Cespedes, M | 1 |
| Charroux, B; Kerridge, S; Tsai, CC; Wang, L | 1 |
11 other study(ies) available for lysine and Head and Neck Neoplasms
| Article | Year |
|---|---|
Lysine 2-hydroxyisobutyrylation proteomics reveals protein modification alteration in the actin cytoskeleton pathway of oral squamous cell carcinoma.
Topics: Actin Cytoskeleton; Carcinoma, Squamous Cell; Chromatography, Liquid; Head and Neck Neoplasms; Humans; Lysine; Mouth Neoplasms; Protein Processing, Post-Translational; Proteomics; Squamous Cell Carcinoma of Head and Neck; Tandem Mass Spectrometry | 2021 |
Knockdown of circGOLPH3 inhibits cell progression and glycolysis by targeting miR-145-5p/lysine demethylase 2A (KDM2A) axis in oral squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; F-Box Proteins; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Lysine; Membrane Proteins; MicroRNAs; Mouth Neoplasms; RNA, Circular; Squamous Cell Carcinoma of Head and Neck | 2023 |
Development and Validation of a Prognostic Signature Based on the Lysine Crotonylation Regulators in Head and Neck Squamous Cell Carcinoma.
Topics: Clinical Relevance; Head and Neck Neoplasms; Humans; Lysine; Prognosis; Squamous Cell Carcinoma of Head and Neck | 2023 |
DNA repair gene polymorphisms and risk of head and neck cancer in the Tunisian population.
Topics: Adenine; Adolescent; Adult; Aged; Aged, 80 and over; Alcohol Drinking; Arginine; Case-Control Studies; DNA Helicases; DNA Repair; DNA Repair Enzymes; DNA-Binding Proteins; Female; Gene-Environment Interaction; Genetic Predisposition to Disease; Glutamine; Guanine; Head and Neck Neoplasms; Humans; Lysine; Male; Middle Aged; Occupational Exposure; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Risk Factors; Smoking; X-ray Repair Cross Complementing Protein 1; Xeroderma Pigmentosum Group D Protein; Young Adult | 2014 |
Inhibition of p300 lysine acetyltransferase activity by luteolin reduces tumor growth in head and neck squamous cell carcinoma (HNSCC) xenograft mouse model.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Proliferation; Chromatin Immunoprecipitation; Flow Cytometry; Head and Neck Neoplasms; Humans; Immunoblotting; Immunohistochemistry; Luteolin; Lysine; Mice; Molecular Docking Simulation; Oligonucleotide Array Sequence Analysis; p300-CBP Transcription Factors; Squamous Cell Carcinoma of Head and Neck; Transcriptome; Xenograft Model Antitumor Assays | 2015 |
WHSC1L1-mediated EGFR mono-methylation enhances the cytoplasmic and nuclear oncogenic activity of EGFR in head and neck cancer.
Topics: Antineoplastic Agents; Biomarkers; Cell Nucleus; Cytoplasm; DNA Replication; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Gene Knockdown Techniques; Head and Neck Neoplasms; Histone-Lysine N-Methyltransferase; Humans; Immunohistochemistry; Lysine; Methylation; Models, Biological; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Protein Binding; Protein Interaction Domains and Motifs; Protein Kinase Inhibitors; Protein Transport | 2017 |
The tumor suppressor gene rap1GAP is silenced by miR-101-mediated EZH2 overexpression in invasive squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; DNA Methylation; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, Tumor Suppressor; GTPase-Activating Proteins; Head and Neck Neoplasms; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; MicroRNAs; Polycomb Repressive Complex 2; Promoter Regions, Genetic; Transcription Factors | 2011 |
Ubiquitin-specific protease 4 promotes TNF-α-induced apoptosis by deubiquitination of RIP1 in head and neck squamous cell carcinoma.
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Down-Regulation; Gene Silencing; Head and Neck Neoplasms; HEK293 Cells; Humans; Immunoprecipitation; Lysine; Neoplasm Proteins; Receptor-Interacting Protein Serine-Threonine Kinases; Recombinant Fusion Proteins; Recombinant Proteins; RNA, Messenger; RNA, Small Interfering; Squamous Cell Carcinoma of Head and Neck; Tumor Necrosis Factor-alpha; Ubiquitin Thiolesterase; Ubiquitin-Specific Proteases; Ubiquitinated Proteins; Ubiquitination; Up-Regulation | 2013 |
Hyperacetylation enhances the growth-inhibitory effect of all-trans retinoic acid by the restoration of retinoic acid receptor beta expression in head and neck squamous carcinoma (HNSCC) cells.
Topics: Acetylation; Antineoplastic Agents; Azacitidine; Carcinoma, Squamous Cell; Cell Line, Tumor; Decitabine; DNA Methylation; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Lysine; Promoter Regions, Genetic; Receptors, Retinoic Acid; Tretinoin | 2005 |
DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Antineoplastic Combined Chemotherapy Protocols; Arginine; Asparagine; Aspartic Acid; Carcinoma, Squamous Cell; Cisplatin; Cysteine; DNA Repair; DNA-Binding Proteins; DNA, Neoplasm; Endonucleases; Female; Gene Frequency; Genotype; Glutamine; Head and Neck Neoplasms; Humans; Lysine; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Survival Analysis; Treatment Outcome; X-ray Repair Cross Complementing Protein 1; Xeroderma Pigmentosum Group D Protein | 2006 |
Atrophin recruits HDAC1/2 and G9a to modify histone H3K9 and to determine cell fates.
Topics: Animals; Cell Line; Cell Lineage; Drosophila melanogaster; Drosophila Proteins; Head and Neck Neoplasms; Histone Deacetylase 1; Histone Deacetylase 2; Histone Deacetylases; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Male; Nerve Tissue Proteins; Protein Binding; Protein Methyltransferases; Protein Structure, Tertiary; Recombinant Fusion Proteins; Repetitive Sequences, Amino Acid; Repressor Proteins | 2008 |